Ahmad Najem

10PUBLICATIONS
23CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 27, 2024
Correction: Krayem et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance. Cancers 2020, 12, 512.

Mohammad Krayem, Philippe Aftimos, Ahmad Najem

|Dec 23, 2023
Correction: Krayem et al. The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. Cancers 2019, 11, 1093.

Mohammad Krayem, Malak Sabbah, Ahmad Najem

|Aug 26, 2023
Macrophage Profiling in Head and Neck Cancer to Improve Patient Prognosis and Assessment of Cancer Cell-Macrophage Interactions Using Three-Dimensional Coculture Models.

Nour Mhaidly, Fabrice Journe, Ahmad Najem

|Jul 29, 2023
Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies.

Ahmad Najem, Mohammad Krayem, Serena Sabbah

|Nov 26, 2022
Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance.

Pashalina Kehagias, Nadège Kindt, Mohammad Krayem

|Apr 12, 2022
Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma.

Ahmad Najem, Laura Soumoy, Malak Sabbah

Pageof 2

Frequent Collaborators

8 joint publications

Mohammad Krayem

4 joint publications

Ahmad Awada

2 joint publications

Laura Soumoy

1 joint publications

Jasper Wouters